SCHEMBL31017625

SCHEMBL31017625

CC(C)(C)OC(=O)N1CCC(c2ccc3c(c2)c2c(Cl)ncnc2n3C(=O)OC(C)(C)C)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR9 Q9NR96 1/20 0.46
▸ TLR8 Q9NR97 1/20 0.46
▸ TLR7 Q9NYK1 1/20 0.46
▸ DDB1 Q16531 1/20 0.42
▸ CRBN Q96SW2 1/20 0.42
▸ NAMPT P43490 1/20 0.41
▸ CNR1 P21554 2/20 0.41
▸ GPR119 Q8TDV5 6/20 0.41
▸ PDE4B Q07343 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ JAK2 O60674 1/20 0.40
▸ JAK1 P23458 1/20 0.40
▸ TYK2 P29597 1/20 0.40
▸ JAK3 P52333 1/20 0.40
▸ PIK3CD O00329 2/20 0.40
▸ SYK P43405 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ USP2 O75604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25830816 1.00 TLR9 (0.46) TLR9TLR8TLR7DDB1CRBN
SCHEMBL25296825 0.95 TLR9 (0.45) TLR9TLR8TLR7DDB1CRBN
SCHEMBL30484134 0.93 TLR9 (0.44) TLR9TLR8TLR7DDB1CRBN
SCHEMBL25831135 0.87 PDE4B (0.47) TLR9TLR8TLR7PDE4BMAPT
SCHEMBL30484120 0.87 PDE4B (0.47) TLR9TLR8TLR7PDE4BMAPT
SCHEMBL25250155 0.87 TLR9 (0.43) TLR9TLR8TLR7DDB1CRBN
SCHEMBL25831704 0.83 DDB1 (0.42) TLR9TLR8TLR7DDB1CRBN
SCHEMBL25260977 0.82 PDE4B (0.46) TLR9TLR8TLR7PDE4BMAPT
SCHEMBL25427387 0.78 DDB1 (0.41) DDB1CRBNGPR119KDM4EMAPT
SCHEMBL30127280 0.76 PDE4B (0.52) TLR9TLR8TLR7DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118414336-A Degradation of Bruton Tyrosine Kinase (BTK) by conjugation of BTK inhibitors to E3 ligase ligands and methods of use 百济神州有限公司 2024-07-30 — — CN disclosed
Send feedback